PSYC Continues To Strengthen Its Leadership Team With Key Appointments To The Sales And Brand Advisory Board
LAKE OSWEGO, OR, January 10, 2022 (GLOBE NEWSWIRE) – Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a media leader for the emerging medicinal psychedelics industry, and the authorities behind Psychedelic Spotlight, a leading psychedelic news and information platform, is pleased to announce that as the company continues to devote considerable attention to strengthening its leadership team, it is proud to ‘welcome Mitchell J. Schlesinger and Sarah Abelsohn to the growing PSYC Advisory Board as additions of key sales and branding experts.
Combined with the recent additions of Christopher Bitonti and Craig Schlesinger, the company believes it effectively complements the PSYC Advisory Board with passionate professionals who can bring a wealth of knowledge and expertise vital to the company and its growing team of Psychedelic Spotlight in the areas of business operations, financial management, marketing, sales and branding.
With over 30 years of experience in creative advertising, strategic marketing and branding, including working for global brands such as Avis Rent-A-Car, Norwegian Cruises, Costa Cruises and Marco Polo Cruises, the company will turn to Mr. Schlesinger. for his guidance and leadership with strategic brand messaging and the development and implementation of sales and marketing key performance indicators (“KPIs”) for its Psychedelic Spotlight media platform, in addition to refine the evolving image of PSYC in the public market sector.
“I have spent my career building brands with unique product positions and innovating them by designing strategic brand implementation programs,” said Mr. Schlesinger. “The emerging psychedelic industry is particularly unique on several fronts and at the forefront of revolutionary medicinal therapies. I look forward to working with the PSYC team to innovate, monetize and consolidate the company’s position as the industry-leading information, multimedia and business platform for consumers and business partners. It is an exciting time to join the dynamic team at PSYC.
Meanwhile, Ms Abelsohn will assume her role as a consultant for PSYC after serving as Director of Psychedelic Spotlight since early 2021. She initially joined the Psychedelic Spotlight team in June 2020 as a Sales and Marketing Consultant and has played a pivotal role in over the past year and a half with the development of the dynamic and industry-leading brand visual aesthetic that is now associated with Psychedelic Spotlight.
“It is a great pride for me to join the PSYC Advisory Board,” said Abelsohn. “I am delighted to continue to bring my knowledge and support to the team and to help impact the growth of our ever-expanding audience for Psychedelic Spotlight. I believe there is so much in store for this talented team, I am honored to have the opportunity to be counsel and excited about what is to come.
“Surrounding the Psychedelic Spotlight team and myself with highly skilled people who are inspired and passionate about what we are building here at PSYC provides us, which I believe, is a very unique competitive advantage in terms of our ability to continue to execute our initiatives focused on fundamental growth and monetization through 2022 and beyond, ”said PSYC CEO David Flores. “In my opinion, a critical part of our existing monetization initiatives is directly related to our ability to develop and deploy effective sales, marketing and branding initiatives. For this reason, I am confident that the additions of Mr. Schlesinger and Ms. Abelsohn to the PSYC Advisory Board will prove to be extremely beneficial to the PSYC due to the dynamic expertise, knowledge and passion they each will be able to. bring in this pivotal period. in the growth of our business.
About Global Trac Solutions, Inc. (OTCPink: PSYC)
At Global Trac Solutions, we integrate media, creativity and technology to develop and deploy stimulating ideas and solutions that advance and transform the approach to some of society’s most pressing issues.
The PSYC has expressed its intention and commitment to position itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities regarding psychedelic-inspired drugs. In conjunction with the FDA’s more open approach to psychedelic drugs, and as several major US cities continue to endorse the decriminalization of psilocybin, we believe investors are speculating that the psychedelic boom may be bigger than that of cannabis. . PSYC is your source for current information on specific investments in psychedelic drugs and cutting-edge research to improve overall health, bringing this industry into the mainstream.
We are dedicated to a forward-thinking approach that encompasses revolutionary new technologies and innovations and, through the vision of business development, we intend to continue to evolve into these uncharted territories as industry leaders of the future. .
Disclaimer Regarding Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “Could”, “in progress,” “plan”, “potential”, “foresee”, “project”, “should”, “will”, “would”, or the negative of these terms or other comparable terminology , although not all forward-looking statements contain these words. Forward-looking statements are not guarantees of future performance or results and will not necessarily be precise indications of when or by which such performance or results will be achieved. forward looking are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors, including the effect of COVID-19 and the success of the current vaccine distribution, l side effect of Omicr one variant, which may cause our results, levels of activity, performance or achievements to differ materially from information expressed or implied by forward-looking statements contained in this press release. This press release should be viewed in light of all documents filed by the Company which are disclosed on the OTC Markets.com website and is not incorporated by reference in any such reports.
Disclaimer: Global Trac Solutions, Inc. does not encourage or condone in any way the use, purchase, sale or transfer of illegal substances, nor does it encourage or condone participation in any activities. illegal. We support a harm reduction approach for the purposes of education and the promotion of individual and public safety. If you choose to use psychedelics, please do so responsibly.
Global Trac Solutions, Inc. (PSYC)